IP Library › Patent Application 17146610
Patent Application
App. No. 17/146,610

NOVEL PHARMACEUTICAL FORMULATIONS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/146,610
Abstract

The present invention relates to new extended release pharmaceutical compositions and methods of use thereof for the treatment of disorders.

Claims (5)

1 . An extended-release pharmaceutical formulation comprising, in a solid dosage form for oral delivery of between about 100 mg and about 1 g total weight:

between about 2 and about 18% of an active ingredient that is tetrabenazine;

between about 70% and about 96% of one or more diluents selected from the group consisting of mannitol powder, spray dried mannitol, microcrystalline cellulose, lactose, dicalcium phosphate, tricalcium phosphate, starch, pregelatinized starch, compressible sugars, silicified microcrystalline cellulose, and calcium carbonate;

between about 1% and about 10% of a water-soluble binder selected from the group consisting of polyvinylpyrrolidone, hydroxypropylcellulose (HPC), hydroxypropylmethylcellulose (HPMC), ethylcellulose (EC), corn starch, pregelatinized starch, gelatin, and sugar; and

between about 0.5 and about 2% of a surfactant selected from the group consisting of polysorbate, sodium lauryl sulfate, and docusate sodium.

Assignments (1)
CHANGE OF ASSIGNEE ADDRESS Recorded Feb 2, 2021
From: AUSPEX PHARMACEUTICALS, INC.
To: AUSPEX PHARMACEUTICALS, INC.
Reel/Frame 055193/0866 →